Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (978)	1/8/1998 11:09:00 PM
From: ernie de la fuente	Respond to of 1359

Good points Neuro! I have read a lot of your writings here. You seem very knowledgeable so I don't have to warn you about the tactics of many brokerage houses. VI

To: NeuroInvestment who wrote (978)	1/16/1998 12:43:00 AM
From: WeirdPro Randy	Read Replies (1) \| Respond to of 1359

On the year end 10-K, under potential products, a drug to deal with alcohol and hepatitis induced cirrhosis was discussed................. Apparently, the company has purchased the exclusive rights to this drug which is currently in phase III studies due for completion in mid-1998. What is really neat about this is the study is being performed and paid for by the government at VA centers, so IPIC's investment is limited for the development of a potentially huge drug........essentially a different ( and better) type of options deal.......... ........I like how this company works!